Evidence against PALB2 involvement in Icelandic breast cancer susceptibility
暂无分享,去创建一个
E. Gillanders | B. Agnarsson | R. Barkardottir | O. Johannsson | G. Johannesdottir | A. Arason | Haukur Gunnarsson
[1] W. Foulkes,et al. Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women , 2007, Breast Cancer Research.
[2] Olufunmilayo I. Olopade,et al. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations , 2007, Nature Reviews Cancer.
[3] Petra M. Nederlof,et al. Analysis of PALB2/FANCN-associated breast cancer families , 2007, Proceedings of the National Academy of Sciences.
[4] Katri Pylkäs,et al. A recurrent mutation in PALB2 in Finnish cancer families , 2007, Nature.
[5] Hans Joenje,et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 , 2007, Nature Genetics.
[6] C. Mathew,et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer , 2007, Nature Genetics.
[7] S. Seal,et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene , 2007, Nature Genetics.
[8] F. Couch,et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. , 2006, Molecular cell.
[9] J. Kere,et al. Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families , 2001, European Journal of Human Genetics.
[10] K. Stefánsson,et al. mtDna and the islands of the North Atlantic: estimating the proportions of Norse and Gaelic ancestry. , 2001, American journal of human genetics.
[11] Jaana M. Hartikainen,et al. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland , 2000, European Journal of Human Genetics.
[12] K. Stefánsson,et al. Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland. , 2000, American journal of human genetics.
[13] A. Jonasdottir,et al. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland. , 1998, Journal of medical genetics.
[14] D. Easton,et al. High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. , 1996, Cancer research.
[15] D. Easton,et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.
[16] N Risch,et al. Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.
[17] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[18] Nazneen Rahman,et al. The emerging landscape of breast cancer susceptibility , 2007, Nature Genetics.
[19] D. Easton,et al. Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families , 2006 .
[20] A. Jonasdottir,et al. Identification of a novel splice‐site mutation of the BRCA1 gene in two breast cancer families: Screening reveals low frequency in Icelandic breast cancer patients , 1998, Human mutation.
[21] Tara L. Naylor,et al. Distinct Genomic Profiles in Hereditary Breast Tumors Identified by Array-based Comparative Genomic Hybridization , 2022 .